Carly Kenselaar

Stock Analyst at Citigroup

(3.09)

# 1,241

Out of 4,670 analysts

5

Total ratings

100%

Success rate

70.39%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Carly Kenselaar

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	TVTX Travere Therapeutics	Maintains: Buy	$23 → $19	$18.25	+4.11%	4	Sep 27, 2024
	KRYS Krystal Biotech	Initiates: Buy	$160	$190.40	-15.97%	1	Oct 12, 2023

Travere Therapeutics

Sep 27, 2024

Maintains: Buy

Price Target: $23 → $19

Current: $18.25

Upside: +4.11%

Krystal Biotech

Oct 12, 2023

Initiates: Buy

Price Target: $160

Current: $190.40

Upside: -15.97%